Multi-omics applied to fibromuscular dysplasia: first steps on a new research avenue

Rosa Maria Bruno¹, Harald Mischak^{2

3}, Alexandre Persu^{4

5}

Affiliations

¹ INSERM U970 Team 7, Paris Cardiovascular Research Centre-PARCC and University Paris Descartes, Paris, France.
² Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
³ Mosaiques Diagnostics GmbH, Hannover, Germany.
⁴ Division of Cardiology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
⁵ Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.

Editorial

Rosa Maria Bruno et al. Cardiovasc Res. 2020.

. 2020 Jan 1;116(1):4-5.

doi: 10.1093/cvr/cvz307.

Rosa Maria Bruno¹, Harald Mischak^{2

3}, Alexandre Persu^{4

5}

¹ INSERM U970 Team 7, Paris Cardiovascular Research Centre-PARCC and University Paris Descartes, Paris, France.
² Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
³ Mosaiques Diagnostics GmbH, Hannover, Germany.
⁴ Division of Cardiology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
⁵ Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.

No abstract available

Comment on

A plasma proteogenomic signature for fibromuscular dysplasia.
Olin JW, Di Narzo AF, d'Escamard V, Kadian-Dodov D, Cheng H, Georges A, King A, Thomas A, Barwari T, Michelis KC, Bouchareb R, Bander E, Anyanwu A, Stelzer P, Filsoufi F, Florman S, Civelek M, Debette S, Jeunemaitre X, Björkegren JLM, Mayr M, Bouatia-Naji N, Hao K, Kovacic JC. Olin JW, et al. Cardiovasc Res. 2020 Jan 1;116(1):63-77. doi: 10.1093/cvr/cvz219. Cardiovasc Res. 2020. PMID: 31424497 Free PMC article.